PAPS ... Prostaglandin Associated Periorbitopathy Syndrome
Prostaglandin analogues (PGAs) are a common choice for glaucoma control because of their effective and convenient nature. However, they may be associated with some side effects defined under the constellation of PAPS. Most of the time, these side effects are well tolerated or not noticed, but it remains important to be aware of them in order to weigh up the benefits and risks of any treatment for glaucoma.
This guidebook will explore PAPS in more detail and provide expert insights to facilitate doctor-patient discussions and provide optimal care.
This pocketbook was created as simplify information from PAPS guidebook. HCPs can provide this pocketbook to your patients after explain about PAPS from guidebook. (if you require printed version, please contact to Santen representative in your country)
This is an educational video for HCPs designed to visually describe the signs of Prostaglandin Associated Peri-orbitopathy Syndrome (PAPS) manifestations in PGA-treated patients, demonstrate the impact of PAPS to physicians’ and patients beyond cosmetic effects.
This is an educational video for patients to understand about PAPS and encourage patients to inform their symptoms to doctors if they experience PAPS symptoms instead of stopping or modify medications by themselves.
This document includes a comprehensive overview of the considerations for ophthalmologists to manage PAPS in Asian patients with glaucoma.
This document includes an overview for ophthalmologists to manage PAPS in Asian PGA patients.